First Header Logo Second Header Logo

Connection

Robert Stratta to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications Robert Stratta has written about Immunosuppressive Agents.
Robert Stratta
Connection Strength
7.951
Immunosuppressive Agents
  1. Stratta RJ. The search for the optimal antibody induction strategy in kidney transplantation: still "hazy" after all these years. Clin Transplant. 2015 Jul; 29(7):569-72.
    View in: PubMed
    Score: 0.444
  2. Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Expert Opin Biol Ther. 2014 Dec; 14(12):1723-30.
    View in: PubMed
    Score: 0.424
  3. Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. Transplant Proc. 2014 Jul-Aug; 46(6):1928-31.
    View in: PubMed
    Score: 0.420
  4. Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014 Jan; 10(1):117-32.
    View in: PubMed
    Score: 0.406
  5. Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009 Sep 27; 88(6):810-9.
    View in: PubMed
    Score: 0.302
  6. Singh RP, Stratta RJ. Advances in immunosuppression for pancreas transplantation. Curr Opin Organ Transplant. 2008 Feb; 13(1):79-84.
    View in: PubMed
    Score: 0.269
  7. Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008 Jan-Feb; 22(1):41-9.
    View in: PubMed
    Score: 0.268
  8. Cartwright MS, Moore PS, Donofrio PD, Iskandar SS, Stratta RJ. Acute sensory neuropathy associated with rabbit antithymocyte globulin. Am J Transplant. 2007 Feb; 7(2):484-6.
    View in: PubMed
    Score: 0.251
  9. Stratta RJ, Alloway RR, Lo A, Hodge EE. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients. Transplant Proc. 2005 Oct; 37(8):3527-30.
    View in: PubMed
    Score: 0.229
  10. Stratta RJ, Alloway RR, Lo A, Hodge EE. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years. Transplant Proc. 2005 Oct; 37(8):3531-4.
    View in: PubMed
    Score: 0.229
  11. Stratta RJ, Sundberg AK, Farney AC, Rohr MS, Hartmann EL, Adams PL. Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage. Transplant Proc. 2005 Oct; 37(8):3546-8.
    View in: PubMed
    Score: 0.229
  12. Sundberg AK, Roskopf JA, Hartmann EL, Farney AC, Rohr MS, Stratta RJ. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation. Transplant Proc. 2005 Mar; 37(2):1294-6.
    View in: PubMed
    Score: 0.220
  13. Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients. Clin Transplant. 2004; 18 Suppl 12:61-6.
    View in: PubMed
    Score: 0.203
  14. Stratta RJ, Alloway RR, Lo A, Hodge E. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study. Transplantation. 2003 Apr 27; 75(8):1260-6.
    View in: PubMed
    Score: 0.194
  15. Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Lo A, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant. 2003; 17 Suppl 9:69-77.
    View in: PubMed
    Score: 0.189
  16. Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Clin Transplant. 2002 Feb; 16(1):60-8.
    View in: PubMed
    Score: 0.178
  17. Bruce DS, Sollinger HW, Humar A, Sutherland DE, Light JA, Kaufman DB, Alloway RR, Lo A, Stratta RJ. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. Transplantation. 2001 Nov 27; 72(10):1637-43.
    View in: PubMed
    Score: 0.175
  18. Stratta RJ, Alloway RR, Lo A, Hodge E. A multicenter trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: interim analysis. Transplant Proc. 2001 Feb-Mar; 33(1-2):1692-3.
    View in: PubMed
    Score: 0.166
  19. Stratta RJ, Gaber AO, Shokouh-Amiri MH, Reddy KS, Alloway RR, Egidi MF, Grewal HP, Gaber LW, Hathaway D. Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. Ann Surg. 1999 May; 229(5):701-8; discussion 709-12.
    View in: PubMed
    Score: 0.147
  20. Stratta RJ. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant. 1999 Feb; 13(1 Pt 1):1-12.
    View in: PubMed
    Score: 0.144
  21. Stratta RJ. Optimal immunosuppression in pancreas transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):619-21.
    View in: PubMed
    Score: 0.144
  22. Stratta RJ. Experience with azathioprine withdrawal after simultaneous kidney-pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1353-4.
    View in: PubMed
    Score: 0.138
  23. Stratta RJ. Sequential pancreas after kidney transplantation: is anti-lymphocyte induction therapy needed? Transplant Proc. 1998 Jun; 30(4):1549-51.
    View in: PubMed
    Score: 0.138
  24. Stratta RJ, Sudan R, Sudan D. Long-term outcomes in simultaneous kidney-pancreas transplant recipients. Transplant Proc. 1998 Jun; 30(4):1564-5.
    View in: PubMed
    Score: 0.138
  25. Stratta RJ. Immunosuppression in pancreas transplantation: progress, problems and perspective. Transpl Immunol. 1998 Jun; 6(2):69-77.
    View in: PubMed
    Score: 0.138
  26. Stratta RJ. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group. Transplant Proc. 1997 Feb-Mar; 29(1-2):654-5.
    View in: PubMed
    Score: 0.126
  27. Stratta RJ, Taylor RJ, Weide LG, Sindhi R, Sudan D, Castaldo P, Cushing KA, Frisbie K, Radio SJ. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. Transplant Proc. 1996 Apr; 28(2):917-8.
    View in: PubMed
    Score: 0.119
  28. Stratta RJ, Taylor RJ, Castaldo P, Sindhi R, Sudan D, Weide LG, Frisbie K, Cushing KA, Jerius J, Radio SJ. FK 506 induction and rescue therapy in pancreas transplant recipients. Transplant Proc. 1996 Apr; 28(2):991-2.
    View in: PubMed
    Score: 0.119
  29. Stratta RJ, Taylor RJ, Castaldo P, Sindhi R, Sudan D, Frisbie K, Cushing K. Preliminary experience with FK 506 in pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3024.
    View in: PubMed
    Score: 0.116
  30. Kaczmorski S, Doares W, Winfrey S, Al-Geizawi S, Farney A, Rogers J, Stratta R. Gout and transplantation: new treatment option-same old drug interaction. Transplantation. 2011 Aug 15; 92(3):e13-4.
    View in: PubMed
    Score: 0.086
  31. Farney AC, Doares W, Kaczmorski S, Rogers J, Stratta RJ. Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA. Immunotherapy. 2010 Nov; 2(6):879-88.
    View in: PubMed
    Score: 0.081
  32. Stratta RJ, Mason B, Lorentzen DF, Sollinger HW, D'Alessandro AM, Pirsch JD, Kalayoglu M, Belzer FO. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch. Transplantation. 1989 Feb; 47(2):282-6.
    View in: PubMed
    Score: 0.072
  33. Singh RP, Farney AC, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann EL, Reeves-Daniel A, Adams PL, Stratta RJ. Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc. 2008 Mar; 40(2):506-9.
    View in: PubMed
    Score: 0.068
  34. Stratta RJ, Armbrust MJ, Oh CS, Pirsch JD, Kalayoglu M, Sollinger HW, Belzer FO. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation. 1988 Feb; 45(2):323-8.
    View in: PubMed
    Score: 0.067
  35. Stratta RJ, Sundberg AK, Rohr MS, Farney AC, Hartmann EL, Roskopf JA, Iskandar SS, Hairston G, Kiger DF, Gautreaux MD, Anderson TK, Adams PL. Optimal use of older donors and recipients in kidney transplantation. Surgery. 2006 Mar; 139(3):324-33.
    View in: PubMed
    Score: 0.059
  36. Stratta RJ, Sundberg AK, Farney AC, Rohr MS, Hartmann EL, Adams PL. Successful simultaneous kidney-pancreas transplantation from extreme donors. Transplant Proc. 2005 Oct; 37(8):3535-7.
    View in: PubMed
    Score: 0.057
  37. Winsett RP, Arheart K, Stratta RJ, Alloway R, Wicks MN, Gaber AO, Hathaway DK. Evaluation of an immunosuppressant side effect instrument. Prog Transplant. 2004 Sep; 14(3):210-6, 240.
    View in: PubMed
    Score: 0.053
  38. Stratta RJ, Rohr MS, Sundberg AK, Armstrong G, Hairston G, Hartmann E, Farney AC, Roskopf J, Iskandar SS, Adams PL. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg. 2004 May; 239(5):688-95; discussion 695-7.
    View in: PubMed
    Score: 0.052
  39. Stratta RJ, Alloway RR, Lo A, Hodge EE. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation? Transplant Proc. 2004 May; 36(4):1076-7.
    View in: PubMed
    Score: 0.052
  40. Stratta RJ, Alloway RR, Lo A, Hodge EE. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab. Transplant Proc. 2004 May; 36(4):1080-1.
    View in: PubMed
    Score: 0.052
  41. Stratta RJ, Rohr MS, Adams PL, Sundberg AK, Hartmann EL, Armstrong G, Anderson TK, Farney AC, Roskopf JA, Hairston G, Kiger DF, Nagaraj SK, Iskandar SS, Assimos DG. Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. Clin Transpl. 2003; 229-45.
    View in: PubMed
    Score: 0.047
  42. Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis. Transplant Proc. 2002 Aug; 34(5):1903-5.
    View in: PubMed
    Score: 0.046
  43. Stratta RJ, Lo A, Shokouh-Amiri M, Egidi MF, Grewal HP, Gaber LW, Gaber AO. Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction. Transplant Proc. 2002 Aug; 34(5):1915-7.
    View in: PubMed
    Score: 0.046
  44. Trofe J, Stratta RJ, Egidi MF, Lo A, Gaber LW, Shokouh-Amiri MH, Grewal HP, Honaker M, Hardinger K, Alloway RR, Gaber AO. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience. Clin Transplant. 2002; 16 Suppl 7:34-44.
    View in: PubMed
    Score: 0.044
  45. Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber LW, Gaber AO. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Transpl Int. 2001 Dec; 14(6):396-404.
    View in: PubMed
    Score: 0.044
  46. Stratta RJ, Gaber AO, Shokouh-Amiri MH, Grewal HP, Egidi MF, Kizilisik AT, Hathaway DK, Gaber LW. A 9-year experience with 126 pancreas transplants with portal enteric drainage. Arch Surg. 2001 Oct; 136(10):1141-9.
    View in: PubMed
    Score: 0.043
  47. Hardinger KL, Stratta RJ, Egidi MF, Alloway RR, Shokouh-Amiri MH, Gaber LW, Grewal HP, Honaker MR, Vera S, Gaber AO. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery. 2001 Oct; 130(4):738-45; discussion 745-7.
    View in: PubMed
    Score: 0.043
  48. Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage. Ann Surg. 2001 Jun; 233(6):740-51.
    View in: PubMed
    Score: 0.042
  49. Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis. 2001 Mar; 3(1):8-15.
    View in: PubMed
    Score: 0.042
  50. Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber AO. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1701-3.
    View in: PubMed
    Score: 0.041
  51. Winsett RP, Stratta RJ, Alloway R, Wicks MN, Hathaway DK. Immunosuppressant side effect profile does not differ between organ transplant types. Clin Transplant. 2001; 15 Suppl 6:46-50.
    View in: PubMed
    Score: 0.041
  52. Mori Ubaldini F, Stratta RJ, Nunez M. Delayed spontaneous hepatitis C virus elimination in a renal transplant patient following graft rejection. Transpl Infect Dis. 2019 Jun; 21(3):e13079.
    View in: PubMed
    Score: 0.036
  53. Stratta RJ. Late acute rejection episodes after vascularized pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1560-1.
    View in: PubMed
    Score: 0.034
  54. Elmer DS, Abdulkarim AB, Fraga D, Shokouh-Amiri H, Stratta RJ, Hathaway DK, Reddy K, Gaber AO. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. Transplant Proc. 1998 Mar; 30(2):523-4.
    View in: PubMed
    Score: 0.034
  55. Stratta RJ, Gaber AO, Shokouh-Amiri MH, Egidi MF, Grewal HP, Reddy KS, Hathaway DK, Winsett RP, Alloway RR, Gaber LW, Britt LG. Experience with portal-enteric pancreas transplant at the University of Tennessee-Memphis. Clin Transpl. 1998; 239-53.
    View in: PubMed
    Score: 0.033
  56. Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation. 1996 Jan 27; 61(2):261-73.
    View in: PubMed
    Score: 0.029
  57. Stratta RJ. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc. 1993 Oct; 25(5 Suppl 4):15-21.
    View in: PubMed
    Score: 0.025
  58. Stratta RJ, Taylor RJ. Prevention and management of hematuria in combined pancreas-kidney transplant recipients with pancreaticoduodenocystostomy. Transplant Proc. 1992 Jun; 24(3):788-90.
    View in: PubMed
    Score: 0.023
  59. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin JJ, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011 May; 11(5):1025-30.
    View in: PubMed
    Score: 0.021
  60. Orlando G, Hematti P, Stratta RJ, Burke GW, Di Cocco P, Cocco PD, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg. 2010 Dec; 252(6):915-28.
    View in: PubMed
    Score: 0.020
  61. Pirsch JD, Armbrust MJ, Stratta RJ, D'Alessandro AM, Sollinger HW, Belzer FO, Kalayoglu M, Maki DG. Perioperative infection in liver transplant recipients under a quadruple immunosuppressive protocol. Transplant Proc. 1989 Jun; 21(3):3559.
    View in: PubMed
    Score: 0.018
  62. D'Alessandro AM, Pirsch JD, Stratta RJ, Sollinger HW, Kalayoglu M, Maki DG, Belzer FO. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation. Transplantation. 1989 Feb; 47(2):297-300.
    View in: PubMed
    Score: 0.018
  63. Hartmann EL, Gatesman M, Roskopf-Somerville J, Stratta R, Farney A, Sundberg A. Management of leukopenia in kidney and pancreas transplant recipients. Clin Transplant. 2008 Nov-Dec; 22(6):822-8.
    View in: PubMed
    Score: 0.018
  64. Kalayoglu M, Stratta RJ, Hoffmann RM, Sollinger HW, Belzer FO. Quadruple immunosuppressive therapy for liver transplantation. Transplant Proc. 1988 Feb; 20(1 Suppl 1):524-9.
    View in: PubMed
    Score: 0.017
  65. Sollinger HW, Stratta RJ, Kalayoglu M, Pirsch JD, Belzer FO. Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression. Surgery. 1987 Oct; 102(4):674-9.
    View in: PubMed
    Score: 0.016
  66. Rogers J, Stratta RJ, Lo A, Alloway RR. Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation. Transplant Proc. 2005 Oct; 37(8):3549-51.
    View in: PubMed
    Score: 0.014
  67. Rogers J, Stratta RJ, Lo A, Alloway RR. Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients. Transplant Proc. 2005 Oct; 37(8):3552-4.
    View in: PubMed
    Score: 0.014
  68. Lo A, Stratta RJ, Alloway RR, Hodge EE. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation. Transplant Proc. 2005 Mar; 37(2):1289-90.
    View in: PubMed
    Score: 0.014
  69. Rogers J, Stratta RJ, Alloway RR, Lo A, Hodge EE. African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression. Transplant Proc. 2004 May; 36(4):1055-7.
    View in: PubMed
    Score: 0.013
  70. Shokouh-Amiri MH, Egidi MF, Lo A, Grewal HP, Vera SR, Stratta RJ, Kizilisik T, Nezakatgoo N, Trofe J, Alloway RR, Cowan PA, Gaber AO. The importance of early prevention of renal dysfunction in liver transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1399-400.
    View in: PubMed
    Score: 0.010
  71. Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik AT, Alloway RR, Gaber AO. Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. Transplant Proc. 2001 Feb-Mar; 33(1-2):1675-7.
    View in: PubMed
    Score: 0.010
  72. Lo A, Stratta RJ, Hathaway DK, Egidi MF, Shokouh-Amiri MH, Grewal HP, Winsett R, Trofe J, Alloway RR, Gaber AO. Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage. Transplant Proc. 2001 Feb-Mar; 33(1-2):1684-6.
    View in: PubMed
    Score: 0.010
  73. Chinnakotla S, Taylor RJ, DeRoover A, Stratta RJ, Leone JP. Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1696-7.
    View in: PubMed
    Score: 0.010
  74. Lo A, Stratta RJ, Egidi MF, Kizilisik AT, Shokouh-Amiri MH, Grewal HP, Trofe J, Alloway RR, Gaber AO. Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. Transplant Proc. 2001 Feb-Mar; 33(1-2):1796-8.
    View in: PubMed
    Score: 0.010
  75. Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik AT, Alloway RR, Gaber LW, Gaber AO. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study. Clin Transplant. 2000 Dec; 14(6):572-9.
    View in: PubMed
    Score: 0.010
  76. Reddy KS, Stratta RJ, Shokouh-Amiri H, Alloway R, Somerville T, Egidi MF, Gaber LW, Gaber AO. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. Transplantation. 2000 Jan 15; 69(1):49-54.
    View in: PubMed
    Score: 0.010
  77. Reddy KS, Stratta RJ, Shokouh-Amiri MH, Alloway R, Egidi MF, Gaber AO. Surgical complications after pancreas transplantation with portal-enteric drainage. J Am Coll Surg. 1999 Sep; 189(3):305-13.
    View in: PubMed
    Score: 0.009
  78. Henley SA, Akhter J, Stratta RJ, Mack-Shipman LR, Miller SJ, Frisbie K, Taylor R, Erickson JM, Leone JP, Lyden E, Ratanasuwan T, Larsen JL. Lipids increase after solitary pancreas transplantation. Diabetes Care. 1999 Feb; 22(2):320-7.
    View in: PubMed
    Score: 0.009
  79. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
    View in: PubMed
    Score: 0.006
  80. Ozaki CF, Stratta RJ, Taylor RJ, Langnas AN, Bynon JS, Shaw BW. Surgical complications in solitary pancreas and combined pancreas-kidney transplantations. Am J Surg. 1992 Nov; 164(5):546-51.
    View in: PubMed
    Score: 0.006
  81. Markin RS, Stratta RJ, Woods GL. Infection after liver transplantation. Am J Surg Pathol. 1990; 14 Suppl 1:64-78.
    View in: PubMed
    Score: 0.005
  82. Kalayoglu M, Stratta RJ, Sollinger HW, Hoffmann RM, D'Alessandro AM, Pirsch JD, Belzer FO. Clinical results in liver transplantation using UW solution for extended preservation. Transplant Proc. 1989 Feb; 21(1 Pt 2):1342-3.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.